Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.

Reid R; Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2010 Dec;32(12):1192-204. English, French.

PMID:
21176332
2.

SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism: an update: no. 252, December 2010.

Reid R, Leyland N, Wolfman W, Allaire C, Awadalla A, Best C, Dunn S, Lemyre M, Marcoux V, Menard C, Potestio F, Rittenberg D, Singh S, Senikas V; Society of Obstetricians and Gynaecologists of Canada.

Int J Gynaecol Obstet. 2011 Mar;112(3):252-6.

PMID:
21416656
3.

Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.

Black A, Guilbert E, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Mansouri S.

J Obstet Gynaecol Can. 2016 Feb;38(2):182-222. doi: 10.1016/j.jogc.2015.12.002. Epub 2016 Feb 26. English, French.

PMID:
27032746
4.

Canadian Contraception Consensus (Part 2 of 4).

Black A, Guilbert E; Co-Authors, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM; Special Contributors, Ferguson C, Fortin C, Kielly M, Mansouri S, Todd N.

J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. English, French.

PMID:
26629725
5.

Canadian Contraception Consensus (Part 1 of 4).

Black A, Guilbert E; Co-Authors, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM; Special Contributors, Ferguson C, Fortin C, Kielly M, Mansouri S, Todd N; Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. English, French.

PMID:
26606712
6.
7.

Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.

Raymond EG, Burke AE, Espey E.

Obstet Gynecol. 2012 May;119(5):1039-44. doi: 10.1097/AOG.0b013e31825194ca.

PMID:
22525916
8.

Hormonal contraceptives and venous thromboembolism: an epidemiological update.

Plu-Bureau G, Maitrot-Mantelet L, Hugon-Rodin J, Canonico M.

Best Pract Res Clin Endocrinol Metab. 2013 Feb;27(1):25-34. doi: 10.1016/j.beem.2012.11.002. Epub 2012 Dec 21. Review.

PMID:
23384743
9.

[Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].

Botzenhardt S, Toni I, Rascher W, Neubert A.

Klin Padiatr. 2013 Sep;225(5):268-76. doi: 10.1055/s-0033-1351288. Epub 2013 Aug 26. Review. German.

PMID:
23979828
11.

Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.

Dinger J, Assmann A, Möhner S, Minh TD.

J Fam Plann Reprod Health Care. 2010 Jul;36(3):123-9. doi: 10.1783/147118910791749416.

12.

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.

Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E.

BMJ. 2011 Oct 25;343:d6423. doi: 10.1136/bmj.d6423.

13.

Epidemiology of hormonal contraceptives-related venous thromboembolism.

Hugon-Rodin J, Gompel A, Plu-Bureau G.

Eur J Endocrinol. 2014 Dec;171(6):R221-30. doi: 10.1530/EJE-14-0527. Epub 2014 Jul 10. Review.

15.

Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.

Sehovic N, Smith KP.

Ann Pharmacother. 2010 May;44(5):898-903. doi: 10.1345/aph.1M649. Epub 2010 Apr 6. Review.

PMID:
20371756
16.

ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.

Committee on Gynecologic Practice.

Obstet Gynecol. 2012 Nov;120(5):1239-42. doi: http://10.1097/AOG.0b013e318277c93b.

PMID:
23090561
17.

Canadian Contraception Consensus (Part 3 of 4): Chapter 8 - Progestin-Only Contraception.

Black A, Guilbert E, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM.

J Obstet Gynaecol Can. 2016 Mar;38(3):279-300. doi: 10.1016/j.jogc.2015.12.003. Epub 2016 Mar 30.

PMID:
27106200
18.

Prenatal screening for fetal aneuploidy in singleton pregnancies.

Chitayat D, Langlois S, Wilson RD; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists.

J Obstet Gynaecol Can. 2011 Jul;33(7):736-50.

PMID:
21749752
19.

Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?

Bird ST, Delaney JA, Etminan M, Brophy JM, Hartzema AG.

J Thromb Haemost. 2013 Jun;11(6):1059-68. doi: 10.1111/jth.12224.

20.

Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?

Han L, Jensen JT.

Obstet Gynecol Clin North Am. 2015 Dec;42(4):683-98. doi: 10.1016/j.ogc.2015.07.007. Epub 2015 Sep 16. Review.

PMID:
26598309

Supplemental Content

Support Center